Skip to main content

Gene Therapy and Cancer

                                              Source- The telegraph UK

Recently, the Telegraph UK published a story that has given a number of cancer patients hope about a cure. Recently a trail conducted by USA's Kita Pharma Research for a new treatment called CAR-T cell therapy has been successful in curing 36 out of 101 patients who have terminal cancer.

How does the treatment work?

The treatment has been referred to as the living drug treatment. It works by filtering a patient's blood to remove key immune system cells called T-cells, which are then genetically engineered in the lab to recognize cancer cells. Cancer cells are very good a evading the immune system, but the new therapy essentially cuts the brakes, allowing immune cells to do their job properly.  

(Source - http://www.telegraph.co.uk/science/2017/02/28/terminal-cancer-patients-complete-remission-one-gene-therapy/)

A whole lot of end stage patients, who has already tried and failed to get better with traditional therapies, have seen their tumors shrink like 'ice cubes' and are in remission after just a single session. 

The doctors however need to check the long term benefits and side effects of this new therapy. There were two people who died during the trail due to the therapy instead of cancer. 

Its sponsor, California-based Kite Pharma, is racing Novartis AG to become the first to win approval of the treatment, called CAR-T cell therapy, in the U.S. It could become the nation’s first approved gene therapy. (Source - http://news.nationalpost.com/health/cancer-patients-in-extraordinary-gene-therapy-study-in-complete-remission-after-one-treatment?__lsa=4285-e285).There were no cases of swelling and fluid in the brain in this or any other study testing Kite’s treatment, company officials said. That contrasts with Juno Therapeutics, which has had a CAR-T study put on hold twice after five patient deaths due to this problem.


Results were released by the company and have not been published or reviewed by other experts. Full results will be presented at the American Association for Cancer Research conference in April.The company plans to seek approval from the U.S. Food and Drug Administration by the end of March and in Europe later this year.

Comments

Popular posts from this blog

Why the new Mental Health bill is being hailed by everyone in India right now

Mental health in India has always been greatly stigmatized. We are extremely judgmental of people who say they are depressed and approach a psychiatrist for the same. We talk behind their back and generally brand them as 'mental case'. It wasn't until recently Deepika Padukone followed by a number of other celebs disclosed being depressed and having various mental ailments that to some level it seems that we have reached a stage where we can atleast have a conversation about it.  Recently the mental health care bill of 2013 was passed, that updated a lot of definitions of what constitutes mental health. It has been hailed by the general public as a step in the right direction. Here are some of the salient features of the bill that have really been appreciated by everyone.    1. First and most importantly, the mental health bill decriminalizes suicide. Viewed as a revolutionary move, the bill acknowledges the various mental factors contributing to a person...

Why does it seem like surrogacy rules do not apply to Karan Johar and other celebrities

Surrogacy laws in India were in news again recently because of Karan Johar who chose to have twins through surrogacy. Recently  the  Law Commission has strongly recommended against Commercial Surrogacy. The Surrogate Bill of 2016 came out with some very stringent laws. A lot has been spoken and told about surrogacy in India. Here is a chance for us to look at the cold hard facts of the matter.  The current surrogacy laws in India: Commercial surrogacy has been legal in India since 2002. 1 .India is emerging as a leader in international surrogacy and a sought after destination in surrogacy-related fertility tourism. Indian surrogates have been increasingly popular with fertile couples in industrialized nations because of the relatively low cost. Indian clinics are at the same time becoming more competitive, not just in the pricing, but in the hiring and retention of Indian females as surrogates. Clinics charge patients roughly a third of the price compared with...

5 questions about Artificial Implantable Kidney to understand it better

Source - http://timesofindia.indiatimes.com/india/artificial-kidney-may-hit-market-by-end-of-decade/articleshow/56801777.cms What is it? An implantable kidney that works due to silicon microchips. These microchips will house living kidney cells that will grow on an around the microchips. These cells will then mimic the natural action of the kidney. How does it work?  It will work in the same way that a regular kidney works with the patients blood flow. The living kidney cells will create membrane that will filter your blood the way a normal kidney does. Also because it is out of reach from the bodys immune system response it cannot be rejected as with an organ transplant. Who is making it? It is being developed by University of California San Francisco (Shuvo Ray) and Vanderbilt University Medical Centre, Nephrology (William H Fissel). Fissell has been working on the implantable artificial kidney for more than a decade with University of California San Franc...